Statistics for Royalty Pharma (id:7133 RPRX)

Valuation metrics

Market cap

15.20B

Enterprise value

21.42B

Trailing P/E (ttm)

10.16

Forward P/E

5.88

PEG ratio

5.88

Price/Sales (ttm)

6.71

Price/Book (mrq)

1.68

Enterprise Value/Revenue

9.45

Enterprise Value/EBITDA

13.63

Overview

Shares outstanding

444.30M

Float

383.87M

Shares short

14.55M

% Held by insiders

0.13%

% Held by institutions

0.73%

Average volume (10 days)

3.34M

Average volume (90 days)

Price summary

52-Week low

25.10

52-Week high

31.66

52-Week change

-2.76%

Beta

0.47

50-Day moving average

27.47

200-Day moving average

28.08

Dividends and splits

Forward annual dividend rate

0.84

Forward annual dividend yield

0.03

Trailing annual dividend rate

0.83%

Trailing annual dividend yield

0.03

5-Year annual dividend yield

Payout ratio

0.33

Dividend date

December 10th, 2024

Ex-dividend date

November 15th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

50.53%

Operating margin

130.17%

Operational effectiveness

Return on assets

5.69%

Return on equity

17.28%

Income statement

Revenue (ttm)

5.06

Revenue per share (ttm)

5.06

Quarterly revenue growth (yoy)

6.54

Gross profit (ttm)

0.00

EBITDA

1.57B

Net income to common (ttm)

1.15B

Diluted EPS (ttm)

2.54

Quarterly earnings growth (yoy)

654.30%

Balance sheet

Total cash (mrq)

998.55M

Total cash per share (mrq)

2.25

Total debt (mrq)

7.61B

Total Debt/Equity (mrq)

74.16

Current ratio (mrq)

153.60%

Book value per share (mrq)

15.40

Cash flow

Cash flow statement

2.80B

Levered free cash flow (LFCF)

-2,120,379,520.00